These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10462343)

  • 1. Anti-retroviral therapy for HIV-infected children--toward maximal effectiveness.
    Melvin AJ
    Pediatr Infect Dis J; 1999 Aug; 18(8):723-4. PubMed ID: 10462343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to triple therapy and viral load response.
    Low-Beer S; Yip B; O'Shaughnessy MV; Hogg RS; Montaner JS
    J Acquir Immune Defic Syndr; 2000 Apr; 23(4):360-1. PubMed ID: 10836763
    [No Abstract]   [Full Text] [Related]  

  • 3. The duration of viral suppression during protease inhibitor therapy for HIV-1 infection is predicted by plasma HIV-1 RNA at the nadir.
    Kempf DJ; Rode RA; Xu Y; Sun E; Heath-Chiozzi ME; Valdes J; Japour AJ; Danner S; Boucher C; Molla A; Leonard JM
    AIDS; 1998 Mar; 12(5):F9-14. PubMed ID: 9543434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection.
    Eron JJ; Yetzer ES; Ruane PJ; Becker S; Sawyer GA; Fisher RL; Tolson JM; Shaefer MS
    AIDS; 2000 Apr; 14(6):671-81. PubMed ID: 10807190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why are the decay rates in plasma HIV-1 different for different treatments and in different patient populations?
    Wu H; Ding AA; De Gruttola V
    AIDS; 1999 Feb; 13(3):429-30. PubMed ID: 10199240
    [No Abstract]   [Full Text] [Related]  

  • 6. Predictors of sustained response to therapy resumption after treatment interruption in HIV-infected patients failing antiretroviral therapy.
    Gianotti N; Soria A; Galli L; Castagna A; Cernuschi M; Hasson H; Lazzarin A
    J Med Virol; 2004 Feb; 72(2):181-6. PubMed ID: 14695657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to medication regimens among children with human immunodeficiency virus infection.
    Reddington C; Cohen J; Baldillo A; Toye M; Smith D; Kneut C; Demaria A; Bertolli J; Hsu HW
    Pediatr Infect Dis J; 2000 Dec; 19(12):1148-53. PubMed ID: 11144374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of and adherence to highly active antiretroviral therapy in children infected with human immunodeficiency virus type 1.
    Watson DC; Farley JJ
    Pediatr Infect Dis J; 1999 Aug; 18(8):682-9. PubMed ID: 10462336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotypic resistance and HIV-1 subtype in Brazilian children on dual and triple combination therapy.
    Machado ES; Lambert JS; Watson DC; Afonso AO; da Cunha SM; Nogueira SA; Caride E; Oliveira RH; Sill AM; DeVico A; Tanuri A
    J Clin Virol; 2004 May; 30(1):24-31. PubMed ID: 15072750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and predictors of virologic failure of antiretroviral triple-drug therapy in a community-based cohort.
    Paris D; Ledergerber B; Weber R; Jost J; Flepp M; Opravil M; Ruef C; Zimmerli S
    AIDS Res Hum Retroviruses; 1999 Dec; 15(18):1631-8. PubMed ID: 10606086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of early initiation of protease inhibitor-sparing antiretroviral regimen in human immunodeficiency virus-1 vertically infected infants.
    Van der Linden D; Hainaut M; Goetghebuer T; Haelterman E; Schmitz V; Maes P; Peltier A; Levy J
    Pediatr Infect Dis J; 2007 Apr; 26(4):359-61. PubMed ID: 17414406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antiretroviral combination therapy (zidovudine/didanosine or zidovudine/lamivudine) on quantitative plasma human immunodeficiency virus-ribonucleic acid in children and adolescents infected with human immunodeficiency virus.
    Sölder B; Wintergerst U; Notheis G; Eberle J; Gürtler L; Belohradsky BH
    J Pediatr; 1997 Feb; 130(2):293-9. PubMed ID: 9042135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of stavudine plus didanosine in asymptomatic HIV-infected children with plasma HIV RNA below 50,000 copies per milliliter.
    de Mendoza C; Ramos JT; Ciria L; Fortuny C; García FJ; de José MI; Asensi F; Soriano V
    HIV Clin Trials; 2002; 3(1):9-16. PubMed ID: 11819180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A trial of three antiretroviral regimens in HIV-1-infected children.
    Luzuriaga K; McManus M; Mofenson L; Britto P; Graham B; Sullivan JL;
    N Engl J Med; 2004 Jun; 350(24):2471-80. PubMed ID: 15190139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy.
    Hermankova M; Ray SC; Ruff C; Powell-Davis M; Ingersoll R; D'Aquila RT; Quinn TC; Siliciano JD; Siliciano RF; Persaud D
    JAMA; 2001 Jul; 286(2):196-207. PubMed ID: 11448283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleoside analogs plus ritonavir in stable antiretroviral therapy-experienced HIV-infected children: a randomized controlled trial. Pediatric AIDS Clinical Trials Group 338 Study Team.
    Nachman SA; Stanley K; Yogev R; Pelton S; Wiznia A; Lee S; Mofenson L; Fiscus S; Rathore M; Jimenez E; Borkowsky W; Pitt J; Smith ME; Wells B; McIntosh K
    JAMA; 2000 Jan; 283(4):492-8. PubMed ID: 10659875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines for the use of antiretroviral agents in pediatric HIV infection, January 7, 2000.
    Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children.
    HIV Clin Trials; 2000; 1(3):58-99. PubMed ID: 11590506
    [No Abstract]   [Full Text] [Related]  

  • 18. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group.
    Haubrich RH; Little SJ; Currier JS; Forthal DN; Kemper CA; Beall GN; Johnson D; Dubé MP; Hwang JY; McCutchan JA
    AIDS; 1999 Jun; 13(9):1099-107. PubMed ID: 10397541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-retroviral treatment of HIV infection in the child].
    De José Gómez MI
    Allergol Immunopathol (Madr); 1998; 26(3):139-44. PubMed ID: 9675397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compact quadruple therapy with the lamivudine/zidovudine combination tablet plus abacavir and efavirenz, followed by the lamivudine/zidovudine/abacavir triple nucleoside tablet plus efavirenz in treatment-naïve HIV-infected adults.
    Ruane PJ; Parenti DM; Margolis DM; Shepp DH; Babinchak TJ; Van Kempen AS; Kauf TL; Danehower SA; Yau L; Hessenthaler SM; Goodwin D; Hernandez JE;
    HIV Clin Trials; 2003; 4(4):231-43. PubMed ID: 12916008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.